10 ADHD Clinical Trials in Sacramento, CA (2026)

Q: How do I join a clinical trial in Sacramento?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you.

Recruiting ADHD Studies in Sacramento

NCT05059444Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that c...

Sacramento, CA2,020 participantsGuardant Health, Inc.

View Study Details

NCT05614739Recruiting

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-435 by itself or when it is combined with other standard medicines that treat cancer. LOXO-435...

Sacramento, CAPHASE1677 participantsEli Lilly and Company

View Study Details

NCT04410302Recruiting

Patient-Derived Xenografts to Reduce Cancer Health Disparities

This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and re...

Sacramento, CA500 participantsUniversity of California, Davis

View Study Details

NCT07097142Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

This phase III trial compares the effect of decreased number of radiation (ultra-hypofractionated) treatments to the usual radiation number of treatments (hypofractionation) with standard of care chem...

Sacramento, CAPHASE3486 participantsNRG Oncology

View Study Details

NCT07106762Recruiting

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

A Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer with Disease Progression on or After Immunotherapy...

Sacramento, CAPHASE2470 participantsBristol-Myers Squibb

View Study Details

NCT04526600Recruiting

Fidgeting and Attentional and Emotional Regulation in ADHD

This project will study how fidgeting relates to cognitive and emotional functioning in adults with attention-deficit/hyperactivity disorder (ADHD). It will determine, in a laboratory setting, whether...

Sacramento, CANA109 participantsUniversity of California, Davis

View Study Details

NCT03952299Recruiting

Oxybutynin for Post-surgical Bladder Pain and Urgency

Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency....

Sacramento, CAPHASE3100 participantsUniversity of California, Davis

View Study Details

NCT03221244Recruiting

Virtual Reality Attention Management

Problems with distraction are widespread in the 21st century, but for people with developmental delays or behavioral challenges they can have more damaging effects. For example, susceptibility to dist...

Sacramento, CANA50 participantsUniversity of California, Davis

View Study Details

NCT06800963Recruiting

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

This is a phase 1/2, open-label, multicenter study of intravesical Recombinant Mycobacterium Bacillus Calmette-Guérin (BCG) in participants with Non-muscle invasive bladder cancer (NMIBC) who have not...

Sacramento, CAPHASE140 participantsImmunityBio, Inc.

View Study Details

NCT06173349Recruiting

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

This phase I trial tests the safety, tolerability and effectiveness of PLZ4-coated paclitacel-loaded micelles (PPM) in treating patients with non-muscle invasive bladder cancer that has come back afte...

Sacramento, CAPHASE112 participantsUniversity of California, Davis

View Study Details

About ADHD Clinical Trials in Sacramento

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.

There are currently 10 adhd clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 4,464 participants. Research is being sponsored by Guardant Health, Inc., Eli Lilly and Company, University of California, Davis and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ADHD Clinical Trials in Sacramento — FAQ

Are there adhd clinical trials in Sacramento?

Yes, there are 10 adhd clinical trials currently recruiting in Sacramento, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What adhd treatments are being tested?

The 10 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.

Data updated August 31, 2026 from ClinicalTrials.gov